June 3, 2025

WRAIR's wallet card helps military leaders support soldiers’ mental health

In February 2025, leadership at Fort Huachuca reached out to the Walter Reed Army Institute of Research for support to develop a new tool to support service members prior to mental health crises. As a result of this request, WRAIR developed the wallet card: an easy-to-field reference with specific guidance for leaders about how to start difficult conversations with their soldiers and work together to figure out next steps.

May 30, 2025

The Promise of Bi-Specific Antibodies to Mitigate HIV Risk to the Battlefield Blood Supply

The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR) has completed enrollment in a Phase 1 human trial in Tanzania to evaluate the safety and antiviral activity of a long-acting bispecific antibody, alone and in combination with another potent monoclonal antibody, to combat HIV.

May 29, 2025

WRAIR-Africa’s Kombewa Clinical Research Center celebrates 27 years of protecting force health

The Kombewa Clinical Research Center celebrated its 27th anniversary on 10 March, 2025 in Kombewa, Kenya. During the event, staff recognized the Center’s 27 years of contributions to protecting the warfighter and the public from medical threats.

May 28, 2025

WRAIR-AFRIMS protects force health at No Sick Soljia 2025

The Walter Reed Army Institute of Research – Armed Forces Research Institute of Medical Sciences conducted disease surveillance in support of exercise No Sick Soljia from 28 March to 14 April in Wewak, Papua New Guinea.

May 27, 2025

WRAIR’s Pilot Bioproduction Facility presents at the World Vaccine Congress 2025

Dr. Jennifer Grossman, business development manager of the Pilot Bioproduction Facility at the Walter Reed Army Institute of Research, presented on the capabilities of the PBF at the annual World Vaccine Congress conference held in Washington D.C., April 2025.

April 17, 2025

WRAIR pursues opportunity to support malaria vaccine development

On March 14, 2025, researchers from the Walter Reed Army Institute of Research met with Dr. Irene Soares, an associate professor at the University of São Paulo, to discuss a possible collaboration on “Vivaxin”, a candidate vaccine against Plasmodium vivax malaria. “Vivaxin” targets the malaria caused by the parasite Plasmodium vivax, a vaccine WRAIR is uniquely positioned to support in preclinical animal studies using P. vivax-infected mosquitos.